Home>Publications>Evaluation of the infliximab (Remicade®) pediatric crohn's disease educational plan
Arana A, Allen S, Burkowitz J. Evaluation of the infliximab (Remicade®) pediatric crohn's disease educational plan. Presented at the 25th International Conference on Pharmacoepidemiology; 2009.
Abstract not available at this time
RTI Health Solutions®
The power of knowledge. The value of understanding.
Steeped in a tradition of rigor and process, we maintain a legacy of setting the scientific standards within our industry. We employ the right approaches and proven research practices to analyze evidence and draw meaningful insights. Our uncompromisingly ethical and objective researchers ensure that results will hold up to scrutiny and reveal the benefits, risks, value and potential of your products. Learn more.